Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual inhibition of PRMT1 and SUV39H1 suppresses breast cancer progression and enhances immunotherapy response. | Int J Biol Sci | 2026 | 42328454 | PubTator, text mining | PubMed |
| Unique Cysteine-Directed Covalent Inhibition of PRMT1 Suppresses Breast Tumorigenesis. | J Med Chem | 2026 | 42309962 | PubTator, text mining | PubMed |
| Dihydrotanshinone I inhibits PHGDH to suppress serine synthesis and remodel TME in NSCLC. | Phytomedicine | 2026 | 42263544 | PubTator, text mining | PubMed |
| PRMT1 drives cervical cancer progression by orchestrating cell growth, migration, and angiogenesis. | Hum Mol Genet | 2026 | 42262225 | PubTator, text mining | PubMed |
| Protein tyrosine kinase-6 is post-translationally regulated by arginine methylation and ubiquitination. | Cell Death Dis | 2026 | 42248824 | PubTator, text mining | PubMed |
| PRMT1-Mediated LDHA Methylation Drives STAT3 Lactylation to Orchestrate Intestinal Inflammation and Tumorigenesis. | Adv Sci (Weinh) | 2026 | 42220092 | PubTator, text mining | PubMed |
| From scaffold to selectivity-medicinal insights of PRMT1 and PRMT4 inhibitors for epigenetic cancer therapy. | RSC Med Chem | 2026 | 42158338 | PubTator, text mining | PubMed |
| Protein Post-Translational Modification-Inspired Regulation of Peptide Coacervation in Living Cells for Pro-Necroptotic Kinase Delivery. | J Am Chem Soc | 2026 | 42133925 | PubTator, text mining | PubMed |
| Progress in molecular markers associated with radiotherapy efficacy in glioma. | Front Oncol | 2026 | 42125691 | PubTator, text mining | PubMed |
| Androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer: Molecular mechanisms and therapeutic strategies. | Urol Oncol | 2026 | 42115122 | PubTator, text mining | PubMed |
| PC3/Tis21/BTG2 and BTG1 genes: regulators of the cell cycle and neurogenesis, as well as tumor suppressors in malignant brain tumors. | Front Cell Dev Biol | 2026 | 42080092 | PubTator, text mining | PubMed |
| PRMT1 and its Substrates: Novel functions in kidney and metabolic diseases. | Diabetes Res Clin Pract | 2026 | 42049098 | PubTator, text mining | PubMed |
| Selective Targeting of Protein Arginine Methyltransferase 1 (PRMT1) Mutant Activity by a Small Molecule Activation Strategy. | ACS Chem Biol | 2026 | 42048414 | PubTator, text mining | PubMed |
| Structural and biochemical characterization of a novel inhibitor of NMNAT1, the gatekeeper of nuclear NAD+ biosynthesis. | bioRxiv | 2026 | 41993279 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| Abstracts from The XXV Brazilian Diabetes Society Meeting. | Diabetol Metab Syndr | 2026 | 41913261 | PubTator, text mining | PubMed |
| PRMT1 facilitates the tumorigenesis of chronic lymphocytic leukemia by regulating methylation of MAST1. | Leukemia | 2026 | 41912914 | PubTator, text mining | PubMed |
| Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma. | Cancer Lett | 2026 | 41903671 | PubTator, text mining | PubMed |
| Ferroptosis in Glioblastoma and Neuroblastoma: Molecular Mechanisms and Novel Therapeutic Strategies. | Curr Issues Mol Biol | 2026 | 41899419 | PubTator, text mining | PubMed |
| A synergistic interaction between PRMT5 and LSD1 inhibitors in AML. | Sci Adv | 2026 | 41894488 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=2